ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer - Update 2023.

Details

Serval ID
serval:BIB_650EF4DE1A4C
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer - Update 2023.
Journal
International journal of gynecological cancer
Author(s)
Cibula D., Raspollini M.R., Planchamp F., Centeno C., Chargari C., Felix A., Fischerová D., Jahnn-Kuch D., Joly F., Kohler C., Lax S., Lorusso D., Mahantshetty U., Mathevet P., Naik R., Nout R.A., Oaknin A., Peccatori F., Persson J., Querleu D., Bernabé S.R., Schmid M.P., Stepanyan A., Svintsitskyi V., Tamussino K., Zapardiel I., Lindegaard J.
ISSN
1525-1438 (Electronic)
ISSN-L
1048-891X
Publication state
Published
Issued date
01/05/2023
Peer-reviewed
Oui
Volume
33
Number
5
Pages
649-666
Language
english
Notes
Publication types: Journal Article ; Research Support, Non-U.S. Gov't
Publication Status: epublish
Abstract
In 2018, the European Society of Gynecological Oncology (ESGO) jointly with the European Society for Radiotherapy and Oncology (ESTRO) and the European Society of Pathology (ESP) published evidence-based guidelines for the management of patients with cervical cancer. Given the large body of new evidence addressing the management of cervical cancer, the three sister societies jointly decided to update these evidence-based guidelines. The update includes new topics to provide comprehensive guidelines on all relevant issues of diagnosis and treatment in cervical cancer.To serve on the expert panel (27 experts across Europe) ESGO/ESTRO/ESP nominated practicing clinicians who are involved in managing patients with cervical cancer and have demonstrated leadership through their expertise in clinical care and research, national and international engagement, profile, and dedication to the topics addressed. To ensure the statements were evidence based, new data identified from a systematic search was reviewed and critically appraised. In the absence of any clear scientific evidence, judgment was based on the professional experience and consensus of the international development group. Before publication, the guidelines were reviewed by 155 independent international practitioners in cancer care delivery and patient representatives.These updated guidelines are comprehensive and cover staging, management, follow-up, long-term survivorship, quality of life and palliative care. Management includes fertility sparing treatment, early and locally advanced cervical cancer, invasive cervical cancer diagnosed on a simple hysterectomy specimen, cervical cancer in pregnancy, rare tumors, recurrent and metastatic diseases. The management algorithms and the principles of radiotherapy and pathological evaluation are also defined.
Keywords
Female, Pregnancy, Humans, Uterine Cervical Neoplasms/pathology, Quality of Life, Radiation Oncology, Medical Oncology, Europe, Cervical Cancer, Pathology, Radiation, Surgical Oncology
Pubmed
Web of science
Open Access
Yes
Create date
08/05/2023 10:32
Last modification date
09/12/2023 7:04
Usage data